Elutia (ELUT) Gains from Investment Securities (2023 - 2026)
Elutia (ELUT) reported Gains from Investment Securities of $1.7 million for Q1 2026, up 131.91% on a YoY basis from $713649.1 in Q1 2025, and up 282.67% sequentially from -$906000.0 in Q4 2025.
Elutia (ELUT) Gains from Investment Securities (2023 - 2026) Analysis & Trends
Elutia (ELUT) has 4 years of Gains from Investment Securities data on file, last reported at $1.7 million in Q1 2026.
- For the quarter ending Q1 2026, Gains from Investment Securities rose 131.91% year-over-year to $1.7 million; the trailing twelve-month figure through Mar 2026 stood at -$6.5 million (down 12227.78% YoY), and the FY2025 full-year result was -$13.4 million, down 190.23% from the prior year.
- Gains from Investment Securities grew to $1.7 million in Q1 2026, from -$906000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $18.3 million in Q2 2024 to a low of -$12.7 million in Q3 2024.
- A 4-year average of $662000.0 and a median of -$906000.0 in 2025 frame the typical range for Gains from Investment Securities.
- Across the five-year window, Gains from Investment Securities sank 1082.52% in 2024 and surged 131.91% in 2026, its largest moves.
- Tracing ELUT's Gains from Investment Securities over 4 years: stood at $5.2 million in 2023, then slumped by 108.5% to -$443000.0 in 2024, then plunged by 104.51% to -$906000.0 in 2025, then soared by 282.67% to $1.7 million in 2026.
- Business Quant data shows ELUT's Gains from Investment Securities at $1.7 million in Q1 2026, -$906000.0 in Q4 2025, and -$5.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Elutia | 40.03 Mn | 11.54 Mn | 1.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.66 Mn |
| Mar 31, 2026 | 1.66 Mn |
| Dec 31, 2025 | -906,000.00 |
| Dec 31, 2025 | -906,000.00 |
| Sep 30, 2025 | -5.10 Mn |
| Sep 30, 2025 | -5.10 Mn |
| Jun 30, 2025 | -2.20 Mn |
| Jun 30, 2025 | -2.20 Mn |
| Mar 31, 2025 | -5.19 Mn |
| Mar 31, 2025 | -5.19 Mn |
| Dec 31, 2024 | -443,000.00 |
| Dec 31, 2024 | -443,000.00 |
| Sep 30, 2024 | -12.65 Mn |
| Sep 30, 2024 | -12.65 Mn |
| Jun 30, 2024 | 18.34 Mn |
| Jun 30, 2024 | 18.34 Mn |
| Mar 31, 2024 | 9.64 Mn |
| Mar 31, 2024 | 9.64 Mn |
| Dec 31, 2023 | 5.21 Mn |
| Dec 31, 2023 | 5.21 Mn |